Literature DB >> 2169723

[3H]naloxone as an opioid receptor label: analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues.

M Schnittler1, C Liebmann, U Schrader, H P Schulze, K Neubert, H Repke.   

Abstract

The nonselective antagonist [3H]naloxone was used to identify opioid receptors in rat brain membranes. The multiple naloxone binding sites were related to different opioid receptors by means of selective opioid ligands as well as various beta-casomorphin analogues. Analysis of binding site heterogeneity was performed using several computer curve fitting methods. The results indicate that structurally modified casomorphin peptides are able to discriminate between mu 1- and mu 2-binding sites. The affinities to the mu-sites obtained with [3H]naloxone as label are in a good agreement with those from experiments with the mu-selective radioligand [3H]DAGO. The mu 1-site affinities of these casomorphin derivatives are well correlated with their antinociceptive potencies. This finding suggests the mediation of the analgesic activity via the high-affinity mu 1-subtype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169723

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  3 in total

1.  Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.

Authors:  Emily Dziedowiec; Sunil U Nayak; Keenan S Gruver; Tyra Jennings; Christopher S Tallarida; Scott M Rawls
Journal:  Neuroscience       Date:  2018-06-27       Impact factor: 3.590

2.  Selective opioid agonist and antagonist competition for [3H]-naloxone binding in amphibian spinal cord.

Authors:  L C Newman; D R Wallace; C W Stevens
Journal:  Brain Res       Date:  2000-11-24       Impact factor: 3.252

3.  In vivo evidence for the unique kinetics of evoked dopamine release in the patch and matrix compartments of the striatum.

Authors:  Andrea Jaquins-Gerstl; Kathryn M Nesbitt; Adrian C Michael
Journal:  Anal Bioanal Chem       Date:  2021-04-12       Impact factor: 4.142

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.